JENSEN-GROUP NV (JEN.BR) Fundamental Analysis & Valuation

EBR:JEN • BE0003858751

Current stock price

63.4 EUR
-0.6 (-0.94%)
Last:

This JEN.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. JEN.BR Profitability Analysis

1.1 Basic Checks

  • In the past year JEN was profitable.
  • JEN had a positive operating cash flow in the past year.
  • In the past 5 years JEN has always been profitable.
  • JEN had a positive operating cash flow in 4 of the past 5 years.
JEN.BR Yearly Net Income VS EBIT VS OCF VS FCFJEN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M

1.2 Ratios

  • With an excellent Return On Assets value of 10.74%, JEN belongs to the best of the industry, outperforming 92.52% of the companies in the same industry.
  • JEN has a Return On Equity of 17.97%. This is amongst the best in the industry. JEN outperforms 85.98% of its industry peers.
  • JEN's Return On Invested Capital of 14.20% is amongst the best of the industry. JEN outperforms 91.59% of its industry peers.
Industry RankSector Rank
ROA 10.74%
ROE 17.97%
ROIC 14.2%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JEN.BR Yearly ROA, ROE, ROICJEN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • JEN has a Profit Margin of 10.63%. This is amongst the best in the industry. JEN outperforms 90.65% of its industry peers.
  • JEN's Profit Margin has improved in the last couple of years.
  • The Operating Margin of JEN (12.57%) is better than 80.37% of its industry peers.
  • In the last couple of years the Operating Margin of JEN has grown nicely.
  • The Gross Margin of JEN (14.50%) is worse than 93.46% of its industry peers.
  • JEN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.57%
PM (TTM) 10.63%
GM 14.5%
OM growth 3Y23.98%
OM growth 5Y18.02%
PM growth 3Y31.44%
PM growth 5Y28.48%
GM growth 3Y22.15%
GM growth 5Y15.33%
JEN.BR Yearly Profit, Operating, Gross MarginsJEN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10

8

2. JEN.BR Health Analysis

2.1 Basic Checks

  • JEN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for JEN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
JEN.BR Yearly Shares OutstandingJEN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
JEN.BR Yearly Total Debt VS Total AssetsJEN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

  • JEN has an Altman-Z score of 4.25. This indicates that JEN is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of JEN (4.25) is better than 87.85% of its industry peers.
  • JEN has a debt to FCF ratio of 1.11. This is a very positive value and a sign of high solvency as it would only need 1.11 years to pay back of all of its debts.
  • JEN has a Debt to FCF ratio of 1.11. This is amongst the best in the industry. JEN outperforms 89.72% of its industry peers.
  • JEN has a Debt/Equity ratio of 0.09. This is a healthy value indicating a solid balance between debt and equity.
  • JEN has a better Debt to Equity ratio (0.09) than 85.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.11
Altman-Z 4.25
ROIC/WACC1.86
WACC7.63%
JEN.BR Yearly LT Debt VS Equity VS FCFJEN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M

2.3 Liquidity

  • JEN has a Current Ratio of 1.98. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
  • JEN has a Current ratio of 1.98. This is in the better half of the industry: JEN outperforms 74.77% of its industry peers.
  • JEN has a Quick Ratio of 1.49. This is a normal value and indicates that JEN is financially healthy and should not expect problems in meeting its short term obligations.
  • JEN's Quick ratio of 1.49 is amongst the best of the industry. JEN outperforms 82.24% of its industry peers.
Industry RankSector Rank
Current Ratio 1.98
Quick Ratio 1.49
JEN.BR Yearly Current Assets VS Current LiabilitesJEN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. JEN.BR Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 124.54% over the past year.
  • JEN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 44.99% yearly.
  • The Revenue has grown by 77.40% in the past year. This is a very strong growth!
  • Measured over the past years, JEN shows a quite strong growth in Revenue. The Revenue has been growing by 17.13% on average per year.
EPS 1Y (TTM)124.54%
EPS 3Y43.69%
EPS 5Y44.99%
EPS Q2Q%204.39%
Revenue 1Y (TTM)77.4%
Revenue growth 3Y16.54%
Revenue growth 5Y17.13%
Sales Q2Q%139.44%

3.2 Future

  • Based on estimates for the next years, JEN will show a decrease in Earnings Per Share. The EPS will decrease by -5.25% on average per year.
  • JEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.71% yearly.
EPS Next Y6.35%
EPS Next 2Y4.98%
EPS Next 3Y-5.25%
EPS Next 5YN/A
Revenue Next Year2.52%
Revenue Next 2Y2.59%
Revenue Next 3Y2.52%
Revenue Next 5Y0.71%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
JEN.BR Yearly Revenue VS EstimatesJEN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
JEN.BR Yearly EPS VS EstimatesJEN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6

7

4. JEN.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 6.53, the valuation of JEN can be described as very cheap.
  • JEN's Price/Earnings ratio is rather cheap when compared to the industry. JEN is cheaper than 97.20% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, JEN is valued rather cheaply.
  • A Price/Forward Earnings ratio of 9.14 indicates a reasonable valuation of JEN.
  • JEN's Price/Forward Earnings ratio is rather cheap when compared to the industry. JEN is cheaper than 86.92% of the companies in the same industry.
  • JEN is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.51, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 6.53
Fwd PE 9.14
JEN.BR Price Earnings VS Forward Price EarningsJEN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, JEN is valued a bit cheaper than 60.75% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, JEN is valued a bit cheaper than 60.75% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.35
EV/EBITDA 8.88
JEN.BR Per share dataJEN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • JEN has a very decent profitability rating, which may justify a higher PE ratio.
  • JEN's earnings are expected to decrease with -5.25% in the coming years. This may justify a cheaper valuation.
PEG (NY)1.03
PEG (5Y)0.15
EPS Next 2Y4.98%
EPS Next 3Y-5.25%

3

5. JEN.BR Dividend Analysis

5.1 Amount

  • JEN has a Yearly Dividend Yield of 1.48%.
  • JEN's Dividend Yield is comparable with the industry average which is at 1.54.
  • Compared to the average S&P500 Dividend Yield of 1.90, JEN is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.48%

5.2 History

  • The dividend of JEN decreases each year by -5.10%.
Dividend Growth(5Y)-5.1%
Div Incr Years2
Div Non Decr Years4
JEN.BR Yearly Dividends per shareJEN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1

5.3 Sustainability

  • JEN pays out 18.67% of its income as dividend. This is a sustainable payout ratio.
  • JEN's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP18.67%
EPS Next 2Y4.98%
EPS Next 3Y-5.25%
JEN.BR Yearly Income VS Free CF VS DividendJEN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M
JEN.BR Dividend Payout.JEN.BR Dividend Payout, showing the Payout Ratio.JEN.BR Dividend Payout.PayoutRetained Earnings

JEN.BR Fundamentals: All Metrics, Ratios and Statistics

JENSEN-GROUP NV

EBR:JEN (3/27/2026, 10:24:31 AM)

63.4

-0.6 (-0.94%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-05
Earnings (Next)05-18
Inst Owners8.13%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap610.54M
Revenue(TTM)803.91M
Net Income(TTM)51.98M
Analysts80
Price Target68.85 (8.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.48%
Yearly Dividend0.77
Dividend Growth(5Y)-5.1%
DP18.67%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 6.53
Fwd PE 9.14
P/S 1.25
P/FCF 15.35
P/OCF 11.85
P/B 2.11
P/tB 2.58
EV/EBITDA 8.88
EPS(TTM)9.71
EY15.32%
EPS(NY)6.94
Fwd EY10.94%
FCF(TTM)4.13
FCFY6.51%
OCF(TTM)5.35
OCFY8.44%
SpS50.78
BVpS30.04
TBVpS24.59
PEG (NY)1.03
PEG (5Y)0.15
Graham Number81.02
Profitability
Industry RankSector Rank
ROA 10.74%
ROE 17.97%
ROCE 18.35%
ROIC 14.2%
ROICexc 15.44%
ROICexgc 18.62%
OM 12.57%
PM (TTM) 10.63%
GM 14.5%
FCFM 8.13%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y23.98%
OM growth 5Y18.02%
PM growth 3Y31.44%
PM growth 5Y28.48%
GM growth 3Y22.15%
GM growth 5Y15.33%
F-Score7
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 1.11
Debt/EBITDA 0.38
Cap/Depr 118.83%
Cap/Sales 2.41%
Interest Coverage 35.71
Cash Conversion 72.22%
Profit Quality 76.51%
Current Ratio 1.98
Quick Ratio 1.49
Altman-Z 4.25
F-Score7
WACC7.63%
ROIC/WACC1.86
Cap/Depr(3y)109.26%
Cap/Depr(5y)111.85%
Cap/Sales(3y)1.98%
Cap/Sales(5y)2.27%
Profit Quality(3y)61.11%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)124.54%
EPS 3Y43.69%
EPS 5Y44.99%
EPS Q2Q%204.39%
EPS Next Y6.35%
EPS Next 2Y4.98%
EPS Next 3Y-5.25%
EPS Next 5YN/A
Revenue 1Y (TTM)77.4%
Revenue growth 3Y16.54%
Revenue growth 5Y17.13%
Sales Q2Q%139.44%
Revenue Next Year2.52%
Revenue Next 2Y2.59%
Revenue Next 3Y2.52%
Revenue Next 5Y0.71%
EBIT growth 1Y36.81%
EBIT growth 3Y44.49%
EBIT growth 5Y38.25%
EBIT Next Year20.29%
EBIT Next 3Y8.35%
EBIT Next 5YN/A
FCF growth 1Y64.85%
FCF growth 3YN/A
FCF growth 5Y8.78%
OCF growth 1Y69.02%
OCF growth 3YN/A
OCF growth 5Y9.72%

JENSEN-GROUP NV / JEN.BR Fundamental Analysis FAQ

What is the fundamental rating for JEN stock?

ChartMill assigns a fundamental rating of 6 / 10 to JEN.BR.


What is the valuation status for JEN stock?

ChartMill assigns a valuation rating of 6 / 10 to JENSEN-GROUP NV (JEN.BR). This can be considered as Fairly Valued.


How profitable is JENSEN-GROUP NV (JEN.BR) stock?

JENSEN-GROUP NV (JEN.BR) has a profitability rating of 7 / 10.


Can you provide the PE and PB ratios for JEN stock?

The Price/Earnings (PE) ratio for JENSEN-GROUP NV (JEN.BR) is 6.53 and the Price/Book (PB) ratio is 2.11.


How financially healthy is JENSEN-GROUP NV?

The financial health rating of JENSEN-GROUP NV (JEN.BR) is 8 / 10.